Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Non Operating Income: 2014-2020

Historic Other Non Operating Income for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to $218,000.

  • Larimar Therapeutics' Other Non Operating Income rose 847.83% to $218,000 in Q1 2020 from the same period last year, while for Mar 2020 it was $220,000, marking a year-over-year increase of 245.70%. This contributed to the annual value of $25,000 for FY2019, which is 110.55% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Other Non Operating Income of $218,000 as of Q1 2020, which was up 282.46% from $57,000 recorded in Q4 2019.
  • Larimar Therapeutics' 5-year Other Non Operating Income high stood at $218,000 for Q1 2020, and its period low was -$97,000 during Q4 2016.
  • For the 3-year period, Larimar Therapeutics' Other Non Operating Income averaged around $666.67, with its median value being -$33,000 (2019).
  • In the last 5 years, Larimar Therapeutics' Other Non Operating Income crashed by 1,375.00% in 2016 and then skyrocketed by 847.83% in 2020.
  • Over the past 5 years, Larimar Therapeutics' Other Non Operating Income (Quarterly) stood at -$97,000 in 2016, then skyrocketed by 125.77% to $25,000 in 2017, then tumbled by 320.00% to -$55,000 in 2018, then skyrocketed by 203.64% to $57,000 in 2019, then spiked by 847.83% to $218,000 in 2020.
  • Its Other Non Operating Income was $218,000 in Q1 2020, compared to $57,000 in Q4 2019 and -$33,000 in Q3 2019.